Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Publication year range
1.
Clin Infect Dis ; 57(1): 139-46, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23511299

ABSTRACT

BACKGROUND: The immunomodulatory nutritional product NR100157 was developed for human immunodeficiency virus (HIV)-infected individuals. We hypothesized that targeting the compromised gastrointestinal tract of HIV-infected individuals would result in systemic immunological benefits. METHODS: In a multicenter, randomized, controlled, double-blind trial, 340 HIV-1-positive adults not on antiretroviral therapy, with CD4(+) T-cell counts <800/µL, were given either NR100157 or an isocaloric and isonitrogenous control for 52 weeks. Primary outcome was CD4(+) T-cell count. Secondary outcomes included plasma viral load (pVL), safety, and tolerability. In a pilot study (n = 20), levels of CD4(+)CD25(+) and CD8(+)CD38(+) activation were measured (n = 20). The trial is registered at the Dutch Trial Register (NTR886) and ISRCTN81868024. RESULTS: At 52 weeks, CD4(+) T-cell decline showed a 40-cell/µL difference (P = .03) in the intention-to-treat population in favor of the immunomodulatory NR100157 (control vs active, -68 ± 15 vs -28 ± 16 cells/µL/year). The change in pVL from baseline was similar between groups (P = .81). In the pilot study, the percentage of CD4(+)CD25(+) was lower in the active group (P < .05) and correlated with changes in CD4(+) T-cell count (r = -0.55, P < .05). The percentage of CD8(+)CD38(+) levels was unaffected. CONCLUSIONS: The specific immunonutritional product NR100157 significantly reduces CD4(+) decline in HIV-1-infected individuals, and this is associated with decreased levels of CD4(+)CD25(+). (This nutritional intervention is likely to affect local gut integrity and gut-associated lymphoid tissue homeostasis, which in turn translates positively to systemic effects.) Clinical Trials Registration. ISRCTN81868024.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Diet/methods , HIV Infections/immunology , HIV Infections/therapy , Immunologic Factors/therapeutic use , Adult , CD4 Lymphocyte Count , CD8-Positive T-Lymphocytes/immunology , Diet/adverse effects , Double-Blind Method , Female , Humans , Immunologic Factors/adverse effects , Male , Middle Aged , Netherlands , Plasma/virology , Treatment Outcome , Viral Load
4.
Rev Biol Trop ; 48(2-3): 511-7, 2000.
Article in English | MEDLINE | ID: mdl-11354959

ABSTRACT

The effect of air pollution on total phyllospheric microflora from two species of the epiphytic neotropical genus Tillandsia (Bromeliaceae) was studied by comparing unpolluted plants living in a forest (Escazú, San José) with polluted ones from an urban site of Costa Rica (San José city). Dilutions of homogenized leaf samples were plated on media suitable for each microbial group. For each microorganism group, total counts were performed and purified strains of randomly chosen colonies were identified. There was a global reduction in the number of living microorganisms due to pollution effects, especially yeasts and bacteria, while nitrogen-fixing microorganisms and fungi were less affected. Our results showed that the phyllosphere microflora of Tillandsia plants living in a tropical urban environment changes in terms of number and species composition of yeasts and bacteria with respect to plants living in unpolluted environment.


Subject(s)
Air Pollution/adverse effects , Plants/microbiology , Bacteria/growth & development , Bacteria/isolation & purification , Costa Rica , Fungi/growth & development , Fungi/isolation & purification , Metals, Heavy/analysis , Plant Leaves/chemistry , Plant Leaves/microbiology , Plants/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL